SAFE, Convertible Note or CCPS: The Instrument Question Startups Can't Skip

The American Bazaar has put a perennial founder dilemma back on the table: when a startup raises money, should it sell a SAFE, issue a convertible note, or price a CCPS round?

The publication frames the choice as a structural one, not a stylistic one. Each instrument carries different consequences for ownership, control and the speed of the deal.

What separates the three instruments?

A SAFE — a Simple Agreement for Future Equity, popularized by Y Combinator — defers valuation entirely. The investor's money converts into shares at a later priced round, usually at a discount or against a valuation cap.

A convertible note does much the same job, but it's debt. It accrues interest and carries a maturity date. If conversion never happens, the note can come due as an obligation the startup must repay.

CCPS — Compulsorily Convertible Preference Shares — is the priced-equity route common in India and other markets. The investor buys preference shares now, at an agreed valuation, with terms that convert them to ordinary equity on defined triggers.

Why does the choice matter?

Speed favors the SAFE. Founders can close a SAFE round in days, with no valuation negotiation and minimal legal drafting.

Certainty favors CCPS. A priced round fixes the ownership math immediately and gives investors defined rights upfront.

Convertible notes sit between the two — faster than priced equity, but with repayment risk and interest terms that SAFEs deliberately strip out.

What should founders weigh?

The American Bazaar's comparison points to the variables that actually drive the decision:

• Stage: very early companies often lack the traction to defend a valuation, which pushes them toward deferred instruments.
• Jurisdiction: CCPS is a standard structure in Indian venture deals; SAFEs dominate in the US seed ecosystem.
• Investor expectations: institutional funds may insist on priced equity before deploying larger checks.
• Dilution discipline: caps, discounts and conversion terms on deferred instruments decide who owns what after the next round.

The instrument a startup picks today sets the terms its future investors will negotiate against. Founders who treat it as boilerplate, rather than deal architecture, tend to learn that at the priced round.

By Amara Osei